The FDA will offer supplemental updates into the Emergency Use Authorization supplies, as correct, if new information and facts emerges. This is the only preventive selection readily available for COVID-19 to the immunocompromised Group, as explained previously mentioned, in the present time. Forbes Health adheres to demanding editorial integrity